1-(1H-Pyrazol-1-yl)propan-2-amine structure 
             | 
        Common Name | 1-(1H-Pyrazol-1-yl)propan-2-amine | ||
|---|---|---|---|---|
| CAS Number | 57939-04-5 | Molecular Weight | 125.17200 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C6H11N3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Name | 1-(1H-Pyrazol-1-yl)-2-propanamine | 
|---|---|
| Synonym | More Synonyms | 
| Molecular Formula | C6H11N3 | 
|---|---|
| Molecular Weight | 125.17200 | 
| Exact Mass | 125.09500 | 
| PSA | 43.84000 | 
| LogP | 0.93060 | 
| 
                                        
                                        
                                        
                                        
                                         ~%  
                                            1-(1H-Pyrazol-1... CAS#:57939-04-5  | 
                                
| Literature: NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; Location in patent: Page/Page column 111 ; WO 2012/018635 A2 | 
| 
                                        
                                        
                                        
                                        
                                         ~96%  
                                            1-(1H-Pyrazol-1... CAS#:57939-04-5  | 
                                
| Literature: CONCERT PHARMACEUTICALS INC.; Tung, Roger Patent: US2014/128469 A1, 2014 ; Location in patent: Paragraph 0110; 0112 ; | 
| 
                                        
                                        
                                        
                                        
                                        
                                        
                                         ~%  
                                            1-(1H-Pyrazol-1... CAS#:57939-04-5  | 
                                
| Literature: NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; WO 2012/018635 A2 | 
| 
                                        
                                        
                                        
                                        
                                        
                                        
                                         ~%  
                                            1-(1H-Pyrazol-1... CAS#:57939-04-5  | 
                                
| Literature: NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; WO 2012/018635 A2 | 
| 4-Methyl-3-nitro-benzoesaeure-methylester | 
| 3-nitro-4-phenoxy-5-sulphamylbenzoic acid methyl ester | 
| methyl 3-nitro-4-phenoxy-5-sulfamoylbenzoate | 
| Methyl 3-nitro-p-toluate | 
| Methyl 3-nitro-4-methylbenzoate | 
| 3-nitro-4-phenoxy-5-sulfamoylbenzoic acid methyl ester | 
| 4-Methyl-3-nitrobenzoic acid methyl ester |